Prevalence and risk factors of prehypertension and hypertension in Algeria.
- World Health Organization (WHO) - STEPS
Algeria
Hypertension
Non-communicable diseases
Prehypertension
Risk factors
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
18 08 2022
18 08 2022
Historique:
received:
12
08
2021
accepted:
27
07
2022
entrez:
18
8
2022
pubmed:
19
8
2022
medline:
23
8
2022
Statut:
epublish
Résumé
Hypertension, also referred to as the silent killer, is known to be one of the most common chronic diseases in the world today. This study aimed to identify the prevalence and risk factors of prehypertension and hypertension among Algerian population. This is a descriptive cross-sectional epidemiological study involving individuals aged 18 to 69 years old who were identified in the database of the national survey on non-communicable diseases (NCDs) risk factors conducted in Algeria between 2016 and 2017 using the World Health Organization's (WHO) STEPwise approach. Differences in prevalence between normotensives, prehypertensives and hypertensives were assessed using the chi-square test. We also looked at the role of numerous socio-demographic, economic, geographical, and behavioural factors in blood pressure status using a logistic regression model. The prevalence of prehypertension and hypertension was 36.2% (95% confidence interval: 35.2-37.5%) and 31.6% (95% CI: 30.5-32.7%) respectively. Prehypertension was shown to be substantially higher in males than in women, while hypertension was found to be higher in females compared to men. In addition, both sexes had a rise in the prevalence of blood pressure as they grew older. A according to multivariate logistic regression analysis, the main common risk factors for prehypertension and hypertension were ageing, obesity, and abdominal obesity. Moreover hypercholesterolemia, and marital status (separated/divorced) were correlated to hypertension. Prehypertension and hypertension are high and epidemic in Algeria. Therefore, the urgent quantification and monitoring of their risk factors becomes a necessity to plan appropriate preventive measures, in order to fight against NCDs in general.
Sections du résumé
BACKGROUND
Hypertension, also referred to as the silent killer, is known to be one of the most common chronic diseases in the world today. This study aimed to identify the prevalence and risk factors of prehypertension and hypertension among Algerian population.
METHODS
This is a descriptive cross-sectional epidemiological study involving individuals aged 18 to 69 years old who were identified in the database of the national survey on non-communicable diseases (NCDs) risk factors conducted in Algeria between 2016 and 2017 using the World Health Organization's (WHO) STEPwise approach. Differences in prevalence between normotensives, prehypertensives and hypertensives were assessed using the chi-square test. We also looked at the role of numerous socio-demographic, economic, geographical, and behavioural factors in blood pressure status using a logistic regression model.
RESULTS
The prevalence of prehypertension and hypertension was 36.2% (95% confidence interval: 35.2-37.5%) and 31.6% (95% CI: 30.5-32.7%) respectively. Prehypertension was shown to be substantially higher in males than in women, while hypertension was found to be higher in females compared to men. In addition, both sexes had a rise in the prevalence of blood pressure as they grew older. A according to multivariate logistic regression analysis, the main common risk factors for prehypertension and hypertension were ageing, obesity, and abdominal obesity. Moreover hypercholesterolemia, and marital status (separated/divorced) were correlated to hypertension.
CONCLUSION
Prehypertension and hypertension are high and epidemic in Algeria. Therefore, the urgent quantification and monitoring of their risk factors becomes a necessity to plan appropriate preventive measures, in order to fight against NCDs in general.
Identifiants
pubmed: 35982441
doi: 10.1186/s12889-022-13942-y
pii: 10.1186/s12889-022-13942-y
pmc: PMC9386961
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1571Informations de copyright
© 2022. The Author(s).
Références
BMC Med. 2015 May 29;13:126
pubmed: 26021319
Hypertension. 2015 Feb;65(2):291-8
pubmed: 25385758
Cardiovasc Diagn Ther. 2018 Aug;8(4):432-438
pubmed: 30214858
Rev Saude Publica. 2012 Dec;46(6):988-98
pubmed: 23503537
PLoS One. 2014 Aug 04;9(8):e104300
pubmed: 25090232
Hum Reprod Update. 2006 Sep-Oct;12(5):483-97
pubmed: 16807276
Int J Adolesc Med Health. 2017 Nov 23;32(2):
pubmed: 29168965
J Hypertens. 2013 Jan;31(1):49-62
pubmed: 23221932
Hypertension. 2005 Jan;45(1):9-14
pubmed: 15583075
Medicine (Baltimore). 2015 Dec;94(50):e1959
pubmed: 26683910
East Mediterr Health J. 2019 Oct 04;25(7):447-456
pubmed: 31612976
J Hum Hypertens. 2013 Oct;27(10):623-8
pubmed: 23575447
Hypertens Res. 2012 Mar;35(3):341-7
pubmed: 22129519
J Hypertens. 2005 Jul;23(7):1355-60
pubmed: 15942457
Am J Hypertens. 1997 Sep;10(9 Pt 1):979-84
pubmed: 9324102
Hypertension. 2007 Jan;49(1):69-75
pubmed: 17159087
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
J Hypertens. 2000 May;18(5):521-9
pubmed: 10826553
Circulation. 2005 Dec 6;112(23):3562-8
pubmed: 16330697
Curr Hypertens Rep. 2016 Aug;18(8):62
pubmed: 27372446
J Hum Hypertens. 1998 Sep;12(9):587-92
pubmed: 9783485
Ann Cardiol Angeiol (Paris). 2013 Feb;62(1):38-42
pubmed: 22677180
Circulation. 1997 Jul 1;96(1):308-15
pubmed: 9236450
BMC Public Health. 2016 Apr 01;16:296
pubmed: 27039079
J Hum Hypertens. 2018 May;32(5):334-348
pubmed: 29230005
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
Lancet. 2001 Nov 17;358(9294):1682-6
pubmed: 11728544
Cardiovasc J Afr. 2013 Jun;24(5):180-3
pubmed: 24217165
Sante. 2007 Jul-Sep;17(3):153-8
pubmed: 18180216
Hypertension. 2003 Jun;41(6):1178-9
pubmed: 12756222
Lancet. 2012 Aug 11;380(9841):611-9
pubmed: 22883510
Am J Hypertens. 2010 Jun;23(6):639-48
pubmed: 20300070
PLoS One. 2017 Jan 17;12(1):e0170238
pubmed: 28095471
Am J Hypertens. 2005 Aug;18(8):1046-51
pubmed: 16109318
Kathmandu Univ Med J (KUMJ). 2007 Jul-Sep;5(3):349-59
pubmed: 18604053
CMAJ. 1999 May 4;160(9 Suppl):S21-8
pubmed: 10333850
Intern Emerg Med. 2020 Jun;15(4):531-535
pubmed: 31628581
Ann Cardiol Angeiol (Paris). 2018 Apr;67(2):61-66
pubmed: 29530274
Rev Epidemiol Sante Publique. 2017 Aug;65(4):277-284
pubmed: 28410864
PLoS One. 2012;7(10):e47632
pubmed: 23077653
J Hypertens. 2009 May;27(5):963-75
pubmed: 19402221
Ann Cardiol Angeiol (Paris). 2017 Jun;66(3):123-129
pubmed: 28554703
Am J Cardiol. 2001 Nov 15;88(10):1218-9
pubmed: 11703983
BMC Res Notes. 2012 Jul 28;5:386
pubmed: 22838639
Nutr Diabetes. 2020 Mar 20;10(1):8
pubmed: 32198350
Int J Environ Res Public Health. 2015 Dec 25;13(1):82
pubmed: 26712776
Nurs Health Sci. 2014 Mar;16(1):126-30
pubmed: 24118852
Eur J Public Health. 2014 Apr;24(2):226-30
pubmed: 23543678
Health Rep. 2009 Sep;20(3):41-52
pubmed: 19813438
BMC Public Health. 2018 May 18;18(1):639
pubmed: 29776343
BMC Public Health. 2014 May 30;14:536
pubmed: 24885853
J Egypt Public Health Assoc. 2015 Sep;90(3):125-32
pubmed: 26544842
J Hypertens. 2007 Nov;25(11):2218-26
pubmed: 17921815
Physiology (Bethesda). 2013 Jul;28(4):234-44
pubmed: 23817798
Glob Cardiol Sci Pract. 2015 Nov 20;2015(4):43
pubmed: 26779518
BMC Med. 2013 Aug 02;11:177
pubmed: 23915102
World J Clin Cases. 2014 Jul 16;2(7):272-8
pubmed: 25032202